13F-HR filed by Prescott General Partners LLC

Prescott General Partners LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 10 holding rows worth $1,231,169,961.

Accession: 0001104659-23-021552
Filer: CIK 1538653
Filed: 2023-02-14
Accepted by EDGAR: acceptance time not in the bulk data set
Ingested: 2026-10-07 18:33:21 UTC
Source: SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 10 entries on the cover page, a total value of $1,231,169,961 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,231,169,961 with VALUE read as dollars as filed, 13F file number 028-14951. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filed	CUSIP	Class	Amount	Value	Value read as
CREDIT ACCEP CORP MICH	225310101	COM	1,560,014	$740,070,642	dollars as filed
WORLD ACCEP CORPORATION	981419104	COM	2,037,495	$134,352,420	dollars as filed
WAYFAIR INC	94419L101	CL A	3,823,239	$125,746,331	dollars as filed
CIMPRESS PLC	G2143T103	SHS EURO	3,906,492	$107,858,244	dollars as filed
YELP INC CL A	985817105	Stock	2,524,750	$69,026,665	dollars as filed
GLOBAL INDUSTRIAL COMPANY COM	37892E102	Stock	1,279,677	$30,110,800	dollars as filed
GRINDR INC	39854F101	COM	4,416,557	$20,536,990	dollars as filed
LINEAGE CELL THERAPEUTICS IN	53566P109	COMMON STOCK	1,851,851	$2,166,666	dollars as filed
HUMACYTE INC	44486Q103	COM	568,246	$1,198,999	dollars as filed
AGEX THERAPEUTICS INC	00848H108	COM	185,185	$102,204	dollars as filed

Amendment chain

Filing	Role	Filed	Accepted	Ingested
13F-HR 0001104659-23-021552	this filing	2023-02-14	acceptance time not in the bulk data set	2026-10-07 18:33:21 UTC